Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci

Citation
Nd. Russell et al., Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci, INFEC IMMUN, 68(4), 2000, pp. 1820-1826
Citations number
47
Categorie Soggetti
Immunology
Journal title
INFECTION AND IMMUNITY
ISSN journal
00199567 → ACNP
Volume
68
Issue
4
Year of publication
2000
Pages
1820 - 1826
Database
ISI
SICI code
0019-9567(200004)68:4<1820:POPHAA>2.0.ZU;2-E
Abstract
Infections with Streptococcus pneumoniae remain a significant cause of morb idity and mortality, To gain insight into structure-function relationships for human antibodies to pneumococcal capsular polysaccharide (PPS)I we stud ied the response of transgenic mice reconstituted with human immunoglobulin loci, XenoMouse, to PPS antigens in a pneumococcal vaccina Enzyme-linked i mmunosorbent assays of sera from mice vaccinated with a 23-valent pneumococ cal vaccine revealed that they produced serotype-specific human antibodies, with the greatest response being to the PPS of serotype 3 (PPS 3, Molecula r sequence analysis of three monoclonal antibodies Ts) to PPS 3 generated f rom lymphoid cells from mite vaccinated with a 23-valent pneumococcal vacci ne or a PPS 3-bovine serum albumin conjugate revealed that they all used he avy-chain immunoglobulin genes from the V(H)3 family, two expressed light c hain genes from the human V kappa 1 family, and one expressed a mouse lambd a light chain. The protective efficacy of the two MAbs was examined in mice . A 10-mu g dose of both, and a 1-mu g dose of one, significantly prolonged survival from a lethal serotype 3 infection in CBA/N mire, Our data show t hat XenoMouse mice produced protective, serotype-specific human antibodies to PPS 3, and they tend support to the proposal that these animals represen t a useful model to study the human antibody response to PPS antigens.